American Society of Hematology

What American Society of Hematology does

The American Society of Hematology (ASH) is the world's largest professional society serving clinicians and scientists working to conquer blood diseases, founded in 1946 and headquartered in Washington, D.C. ASH operates as a 501(c)(3) nonprofit with a member-elected Executive Committee and a workforce of 101–250 employees serving a global membership of more than 17,000 hematologists. The society generates revenue through a diversified mix of membership dues, the flagship ASH Annual Meeting and Exposition (the premier event in hematology, attracting 8,000+ abstract submissions annually), ACCME-accredited continuing medical education programs offering up to 88 AMA PRA Category 1 Credits, the Blood Journals portfolio of seven specialty journals published since 1946, and educational product sales through the ASH Store.

ASH's product portfolio spans research, education, advocacy, and publications. Core platforms include the ASH Academy eLearning platform, ASH Clinical Practice Guidelines, the Quality Improvement Training Institute (QITI), and the ASH Research Collaborative. In April 2026 ASH launched the ASH HematOmics Program (ASHOP), an open-access data integration platform co-developed with St. Jude Children's Research Hospital and the Munich Leukemia Laboratory, consolidating genomic, transcriptomic, and clinical data from 5,960 blood cancer patients. The society also publishes ASH Clinical News and The Hematologist newsletter.

ASH's go-to-market centers on community-led membership engagement, anchored by the annual meeting, advocacy campaigns (#Fight4Hematology), and global initiatives such as the Consortium on Newborn Screening in Africa, which has screened nearly 175,000 newborns for sickle cell disease in coordination with the Africa CDC. The society pursues regulatory and policy influence through coalitions such as Blood Advocacy Week 2026 (100+ organizations) and operates sub-brands including the ASH Foundation, ASH Center for Sickle Cell Disease Initiatives, ASH Job Center, and ASH Image Bank. Pricing is subscription/dues-based for membership and journals, with one-time fees for educational products and CME certificate processing.

Name

American Society of Hematology

Legal name

American Society of Hematology

Website

https://hematology.org

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

251–500 employees

Short description

American Society of Hematology (ASH) is the world's largest professional society serving clinicians and scientists working to conquer blood diseases, with 17,000+ members worldwide. Founded in 1946 and headquartered in Washington, D.C., ASH operates as a nonprofit delivering the Blood Journals portfolio, the ASH Annual Meeting, ACCME-accredited CME, clinical practice guidelines, and the ASH HematOmics Program data platform.

Ownership category

akta.pro rank

Product category

Professional Medical Society

NAICS

Newspaper, Periodical, Book, and Directory Publishers (5131)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Inpatient Rehabilitation Facilities (IRF) (HLAFAFAA)

Keywords

• Hematology professional society
• Medical education and CME
• Scientific publishing
• Clinical practice guidelines
• Medical research advocacy

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Membership Dues: ASH generates revenue through membership dues from over 17,000 hematologists worldwide. Membership offers benefits including access to publications, education programs, advocacy representation, and networking opportunities.
2. Annual Meeting and Events: The ASH Annual Meeting and Exposition is a major revenue generator, with registration fees, CME credit processing fees ($50 per certificate), and exhibit space sales.
3. Continuing Medical Education: ASH offers accredited CME programs including the ASH Annual Meeting (up to 70 AMA PRA Category 1 Credits), Highlights of ASH in North America (up to 13 credits), Hematology Education Program (up to 88 credits), and ASH Self-Assessment Program (up to 45 credits).
4. Publications Revenue: ASH publishes the Blood Journals (including Blood, Blood Advances, Blood Neoplasia, Blood Vessels Thrombosis & Hemostasis, Blood Global Hematology, Blood Immunology & Cellular Therapy, Blood Red Cells & Iron), The Hematologist, and ASH Clinical News.
5. ASH Store and Products: ASH sells educational products, publications, and merchandise through the ASH Store, including the ASH Self-Assessment Program textbook (Ninth Edition with 49 chapters and 254 multiple-choice questions).

Pricing tiers

Go-to-market motion1 record

Distribution channels7 records

Marketing channels8 records

Core offering

The American Society of Hematology is a professional membership society that delivers hematology-focused research, education, publications, clinical practice guidelines, advocacy, and networking services to more than 17,000 clinicians and scientists worldwide. Its core offerings include the ASH Annual Meeting and Exposition, the Blood Journals portfolio, the ASH Academy eLearning platform, the ASH Self-Assessment Program, clinical practice guidelines, and the ASH HematOmics Program (ASHOP) data integration platform. Revenue is generated primarily through membership dues, meeting registration, publication subscriptions, and educational product sales.

Product overview

The American Society of Hematology offers a comprehensive portfolio of products and services focused on conquering blood diseases worldwide. The core offerings include the ASH Annual Meeting and Exposition (the premier event in hematology), the ASH Academy eLearning platform, ASH Self-Assessment Program (ASH-SAP), and the Hematology Education Program publication. ASH has also launched the HematOmics Program (ASHOP), a data integration platform for blood cancer research developed with St. Jude Children's Research Hospital and Munich Leukemia Laboratory. ASH publishes the Blood Journals portfolio (including Blood, Blood Advances, and specialty journals focused on Blood Neoplasia, Blood Vessels/Thrombosis & Hemostasis, Blood Global Hematology, Blood Immunology & Cellular Therapy, and Blood Red Cells & Iron), ASH Clinical News, and The Hematologist newsletter. Additional offerings include Clinical Practice Guidelines, the Quality Improvement Training Institute (QITI), ASH Research Collaborative, ASH Image Bank, and ASH Job Center.

Differentiator

Problem solved

Functional benefit

Brands

• ASH Foundation: The philanthropic arm of ASH that supports hematology research through awards and grants to advance the field and patient care.
• ASH Research Collaborative
• ASH Academy
• ASH Job Center
• ASH Image Bank
• ASH HematOmics Program (ASHOP)
• ASH Clinical News
• The Hematologist: ASH News and Reports
• Blood Journals
• ASH Center for Sickle Cell Disease Initiatives
• ASH Self-Assessment Program (ASH-SAP)
• Quality Improvement Training Institute (QITI)

Products and services

• ASH Annual Meeting and Exposition
• ASH Academy
• ASH Self-Assessment Program (ASH-SAP), Ninth Edition
• Hematology, ASH Education Program
• ASH Clinical Practice Guidelines
• Quality Improvement Training Institute (QITI)
• ASH HematOmics Program (ASHOP)
• Blood Journals Portfolio
• ASH Clinical News
• The Hematologist: ASH News and Reports
• ASH Research Collaborative
• Highlights of ASH in North America

Quantifiable outcome

• Over 5,000 abstracts presented annually at the ASH Annual Meeting
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Blood Advocacy Week 2026 CoalitioncoreGTM or Marketing Partner · 8 June 2026Over 100 organizations launched Blood Advocacy Week 2026 in Washington, D.C., urging Congress to prioritize the blood supply as a national issue. ASH is a leading participant in this coalition advocating for prehospital blood transfusions, cybersecurity for blood centers, and modernized regulations.
• St. Jude Children's Research HospitalcoreStrategic or Co-development Partner · 6 April 2026Collaborated with ASH and Munich Leukemia Laboratory to develop the ASH HematOmics Program (ASHOP), a data-sharing platform that unifies genomics, gene expression, and clinical data from 5,960 blood cancer patients. St. Jude scientists contributed to developing this open-access resource for blood cancer research.
• Munich Leukemia LaboratorycoreStrategic or Co-development Partner · 6 April 2026Collaborated with ASH and St. Jude Children's Research Hospital to develop the ASH HematOmics Program (ASHOP), integrating whole genome sequencing, whole transcriptome sequencing, and clinical outcomes data.
• Cure HHTminorStrategic or Co-development Partner · 20 October 2025Cure HHT's research abstract derived from the Comprehensive HHT Outcomes Registry of the United States (CHORUS) was selected for oral presentation at the ASH 2025 Annual Meeting, aiming to increase awareness of hereditary hemorrhagic telangiectasia in the hematology community.
• Telo GenomicsminorStrategic or Co-development Partner · 9 October 2025Telo Genomics' abstract on Minimal Residual Disease (MRD) methodology was accepted for presentation at the 2025 ASH Annual Meeting. The company is developing non-invasive diagnostic tests for blood cancers, particularly multiple myeloma.
• Africa CDCcoreStrategic or Co-development Partner · 1 April 2025Africa CDC unveiled a continental plan for sickle cell disease and other inherited disorders, with implementation built on a technical working group established in April 2025. ASH supports initiatives through the Consortium on Newborn Screening in Africa.
• Consortium on Newborn Screening in AfricacoreStrategic or Co-development Partner · 1 April 2025A consortium supported by ASH that has screened nearly 175,000 newborns, demonstrating that large-scale sickle cell disease screening is feasible across multiple African countries. The goal is to save over 95% of babies born with sickle cell disease in sub-Saharan Africa.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• American Society of Hematologic Oncology (SOHO): SOHO is a smaller, more focused hematologic oncology society that runs an annual meeting and education programs competing with ASH for malignant hematology members. Comparable niche within ASH's broader mandate, though at materially smaller scale.

Broad incumbents

• American Medical Association (AMA): AMA is the largest U.S. physician membership organization, operating JAMA and the JAMA Network journals, an annual meeting, advocacy, and education. Comparable as a broad-based medical society business model, though serving all physicians rather than a single specialty.
• American Heart Association (AHA): AHA is a much larger analog nonprofit health organization with a comparable mix of scientific journals (Circulation), annual meetings, advocacy campaigns, CME, and clinical guidelines, serving cardiovascular specialists. Useful benchmark for ASH's society and revenue model at greater scale.

Direct peers

• American Association for Cancer Research (AACR): AACR is a closely related medical society that publishes top-tier journals (Cancer Discovery, Blood Cancer variants), runs a large annual meeting (AACR Annual Meeting), and operates research grant programs. Strong overlap with ASH in hematologic malignancy research and translational science.
• American Society of Pediatric Hematology/Oncology (ASPHO): ASPHO is a smaller subspecialty society focused on pediatric hematology/oncology that overlaps with ASH's trainee and pediatric members. Comparable society structure (annual meeting, journal, education, advocacy) though at a smaller scale than ASH.
• American Society of Clinical Oncology (ASCO): ASCO is the closest peer to ASH: a similarly structured U.S.-based professional medical society focused on oncology/hematology-oncology that runs a flagship annual meeting (ASCO Annual Meeting), publishes peer-reviewed journals (JCO, JCO Oncology Advances), provides CME, develops clinical guidelines, and advocates for federal research funding. Direct overlap in malignant hematology membership.
• European Hematology Association (EHA): EHA is the primary international counterpart to ASH, serving European hematologists with a parallel portfolio including the EHA Annual Congress, the Haematologica journal, clinical guidelines, and educational programs. Directly comparable in mission, membership model, and publication footprint.
• American College of Physicians (ACP): ACP is a large internal medicine professional society with a parallel product set including the Annals of Internal Medicine journal, an annual meeting (Internal Medicine Meeting), MOC/CME programs, and clinical guidelines. Comparable operating model and member-base structure to ASH.
• International Society on Thrombosis and Haemostasis (ISTH): ISTH serves the hematology subspecialty of thrombosis, hemostasis, and vascular biology — areas where ASH publishes the journal Blood Vessels, Thrombosis & Hemostasis. Comparable society structure with global membership and an annual scientific congress.
• American Society for Transplantation and Cellular Therapy (ASTCT): ASTCT covers hematopoietic stem cell transplantation and cellular therapy, an area overlapping with ASH's Blood Immunology & Cellular Therapy journal and the clinical hematology community ASH serves. Operates a similar society model with annual meeting, journal, and clinical guidelines.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ash_hematology
• Facebookfacebook.com/AmericanSocietyofHematology
• LinkedInlinkedin.com/company/american-society-of-hematology

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Society of Hematology